Lawmakers "Don't Care" About Safety Concerns With Rx Imports - GSK
This article was originally published in The Pink Sheet Daily
Executive Summary
Congress' push to pass legislation that would legalize drug importation shows that it has placed political matters ahead of safety concerns, GlaxoSmithKline said Sept. 14 at the Bear Stearns health care conference in New York.